PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9811480-5 1998 Alginate/heparin-Sepharose microspheres and films were designed as drug carriers to control release the bFGF-SAP conjugate or bFGF alone in small doses. Sepharose 17-26 fibroblast growth factor 2 Bos taurus 104-108 9811480-5 1998 Alginate/heparin-Sepharose microspheres and films were designed as drug carriers to control release the bFGF-SAP conjugate or bFGF alone in small doses. Sepharose 17-26 fibroblast growth factor 2 Bos taurus 126-130 1854718-8 1991 The cementum mitogenic factor eluting with 2.0 M NaCl from a heparin-Sepharose column was shown to be basic fibroblast growth factor (bFGF) on the basis of inhibition by anti-bFGF antibody and Western blots. Sepharose 69-78 fibroblast growth factor 2 Bos taurus 102-132 8168085-6 1994 Agarose gel electrophoresis of DNA extracted from irradiated bovine aortic endothelial cells showed that both TPA (30 ng/ml; 30 min) and bFGF (1 ng/ml) inhibited the apoptotic degradation of DNA induced in these cells by radiation exposure (500 cGy). Sepharose 0-7 fibroblast growth factor 2 Bos taurus 137-141 9378778-4 1997 Ethidium bromide/agarose gel electrophoresis on the cytosolic fraction of BME cells revealed a basal level of fragmented DNA that was increased by anti-bFGF antibodies to an extent not exceeding that observed in parallel cultures incubated with concentrations of transforming growth factor-ss1 that increase VEGF-induced in vitro angiogenesis. Sepharose 17-24 fibroblast growth factor 2 Bos taurus 152-156 1854718-8 1991 The cementum mitogenic factor eluting with 2.0 M NaCl from a heparin-Sepharose column was shown to be basic fibroblast growth factor (bFGF) on the basis of inhibition by anti-bFGF antibody and Western blots. Sepharose 69-78 fibroblast growth factor 2 Bos taurus 134-138 2153562-2 1990 The activity binds to heparin-Sepharose and it is quenched by polyclonal anti-human placental basic fibroblast growth factor (bFGF) antibodies. Sepharose 30-39 fibroblast growth factor 2 Bos taurus 94-124 1710230-6 1991 The mitogens extracted from cell lysates and from the ECM are closely related to aFGF or bFGF by the criteria that they bind to heparin-sepharose and elute at 1.1 M (aFGF) or 1.5 M (bFGF) NaCl, have molecular weights of about 18,000, and react with anti-aFGF (1.1 M), or anti-bFGF (1.5 M) antibodies when analyzed by Western blots and by radioimmunoassay specific for aFGF and bFGF. Sepharose 136-145 fibroblast growth factor 2 Bos taurus 89-93 1988290-2 1991 Biologically active immunoreactive Mr 18,000 bFGF can be isolated by heparin-Sepharose affinity chromatography from the extract of GM 7372 cell nuclei. Sepharose 77-86 fibroblast growth factor 2 Bos taurus 45-49 2170425-2 1990 Iodinated 125I-bFGF diffuses further in agarose, fibrin, and on a monolayer of bovine aortic endothelial (BAE) cells in the presence of heparin than in its absence. Sepharose 40-47 fibroblast growth factor 2 Bos taurus 15-19 2153562-2 1990 The activity binds to heparin-Sepharose and it is quenched by polyclonal anti-human placental basic fibroblast growth factor (bFGF) antibodies. Sepharose 30-39 fibroblast growth factor 2 Bos taurus 126-130 2153562-3 1990 In the serum-free conditioned medium of FBAE cells, the anti-bFGF antiserum recognizes an immunorective Mr 20,000 molecule which co-purifies with the mitogenic and PA-inducing activity on a heparin-Sepharose column. Sepharose 198-207 fibroblast growth factor 2 Bos taurus 61-65 2550084-8 1989 Affinity chromatography with bFGF immobilized on Sepharose 4B was then performed. Sepharose 49-61 fibroblast growth factor 2 Bos taurus 29-33 2550084-9 1989 Covalent fixation of bFGF to the Sepharose matrix was carried out in presence of N-acetylated heparin in order to protect the recognition site for bFGF on its receptor. Sepharose 33-42 fibroblast growth factor 2 Bos taurus 21-25 2550084-9 1989 Covalent fixation of bFGF to the Sepharose matrix was carried out in presence of N-acetylated heparin in order to protect the recognition site for bFGF on its receptor. Sepharose 33-42 fibroblast growth factor 2 Bos taurus 147-151 2783905-5 1989 Heparin-Sepharose fractionation of cell extracts revealed that bone cells contained a basic FGF (bFGF)-like molecule, that displayed high affinity for heparin. Sepharose 8-17 fibroblast growth factor 2 Bos taurus 86-95 2783905-5 1989 Heparin-Sepharose fractionation of cell extracts revealed that bone cells contained a basic FGF (bFGF)-like molecule, that displayed high affinity for heparin. Sepharose 8-17 fibroblast growth factor 2 Bos taurus 97-101 3417781-3 1988 The inhibitory effect of the immunoglobulins is dependent upon antibody concentration, is reversible, is overcome by the addition of recombinant bFGF, and is removed by affinity chromatography of the antiserum through a column of bFGF-Sepharose. Sepharose 235-244 fibroblast growth factor 2 Bos taurus 145-149 3417781-3 1988 The inhibitory effect of the immunoglobulins is dependent upon antibody concentration, is reversible, is overcome by the addition of recombinant bFGF, and is removed by affinity chromatography of the antiserum through a column of bFGF-Sepharose. Sepharose 235-244 fibroblast growth factor 2 Bos taurus 230-234 3396587-4 1988 VSM cells contain 3.7 and 7.0 kilobase bFGF gene transcripts, which are translated into material closely related, if not identical, with bFGF when analyzed by its chromatographic behavior on heparin Sepharose, by immunoblot and by radioimmuno- and radioreceptor assays. Sepharose 199-208 fibroblast growth factor 2 Bos taurus 39-43